374 related articles for article (PubMed ID: 18205365)
21. Total synthesis and biological evaluation of largazole and derivatives with promising selectivity for cancers cells.
Zeng X; Yin B; Hu Z; Liao C; Liu J; Li S; Li Z; Nicklaus MC; Zhou G; Jiang S
Org Lett; 2010 Mar; 12(6):1368-71. PubMed ID: 20184338
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic labdane alkaloids from an ascidian Lissoclinum sp.: isolation, structure elucidation, and structure-activity relationship.
Uddin J; Ueda K; Siwu ER; Kita M; Uemura D
Bioorg Med Chem; 2006 Oct; 14(20):6954-61. PubMed ID: 16854586
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Avallone E; Smith CD; Gomez-Paloma L; Riccio R
Bioorg Med Chem; 2005 Sep; 13(17):5225-39. PubMed ID: 16023351
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of c7-demethyl largazole analogues.
Chen F; Gao AH; Li J; Nan FJ
ChemMedChem; 2009 Aug; 4(8):1269-72. PubMed ID: 19431162
[No Abstract] [Full Text] [Related]
25. Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor.
Bowers A; West N; Taunton J; Schreiber SL; Bradner JE; Williams RM
J Am Chem Soc; 2008 Aug; 130(33):11219-22. PubMed ID: 18642817
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiproliferative evaluation of 4-anilino-n-methoxyfuro[2,3-b]quinoline derivatives (n=6, 7). Part 5.
Chen YL; Lin HC; Yang CN; Lu PJ; Tzeng CC
Chem Biodivers; 2008 Feb; 5(2):267-78. PubMed ID: 18293440
[TBL] [Abstract][Full Text] [Related]
27. Jizanpeptins, Cyanobacterial Protease Inhibitors from a Symploca sp. Cyanobacterium Collected in the Red Sea.
Gallegos DA; Saurí J; Cohen RD; Wan X; Videau P; Vallota-Eastman AO; Shaala LA; Youssef DTA; Williamson RT; Martin GE; Philmus B; Sikora AE; Ishmael JE; McPhail KL
J Nat Prod; 2018 Jun; 81(6):1417-1425. PubMed ID: 29808677
[TBL] [Abstract][Full Text] [Related]
28. Cytoskeleton alterations induced by Geodia corticostylifera depsipeptides in breast cancer cells.
Rangel M; Prado MP; Konno K; Naoki H; Freitas JC; Machado-Santelli GM
Peptides; 2006 Sep; 27(9):2047-57. PubMed ID: 16843570
[TBL] [Abstract][Full Text] [Related]
29. Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.
Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Paul VJ
J Nat Prod; 1999 Apr; 62(4):655-8. PubMed ID: 10217737
[TBL] [Abstract][Full Text] [Related]
30. Total structure and inhibition of tumor cell proliferation of laxaphycins.
Bonnard I; Rolland M; Salmon JM; Debiton E; Barthomeuf C; Banaigs B
J Med Chem; 2007 Mar; 50(6):1266-79. PubMed ID: 17323939
[TBL] [Abstract][Full Text] [Related]
31. Comparative pharmacokinetic properties and antitumor activity of the marine HDACi Largazole and Largazole peptide isostere.
Pilon JL; Clausen DJ; Hansen RJ; Lunghofer PJ; Charles B; Rose BJ; Thamm DH; Gustafson DL; Bradner JE; Williams RM
Cancer Chemother Pharmacol; 2015 Apr; 75(4):671-82. PubMed ID: 25616967
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationship of cytotoxic marine cyclodepsipeptide IB-01212 analogues.
Cruz LJ; Francesch A; Cuevas C; Albericio F
ChemMedChem; 2007 Jul; 2(7):1076-84. PubMed ID: 17514692
[TBL] [Abstract][Full Text] [Related]
33. N-methylsansalvamide a peptide analogues. Potent new antitumor agents.
Liu S; Gu W; Lo D; Ding XZ; Ujiki M; Adrian TE; Soff GA; Silverman RB
J Med Chem; 2005 May; 48(10):3630-8. PubMed ID: 15887970
[TBL] [Abstract][Full Text] [Related]
34. Largazole: from discovery to broad-spectrum therapy.
Hong J; Luesch H
Nat Prod Rep; 2012 Apr; 29(4):449-56. PubMed ID: 22334030
[TBL] [Abstract][Full Text] [Related]
35. Novel iodinated diterpenes from a marine cyanobacterium and red alga assemblage.
Williams PG; Yoshida WY; Moore RE; Paul VJ
Org Lett; 2003 Oct; 5(22):4167-70. PubMed ID: 14572276
[TBL] [Abstract][Full Text] [Related]
36. Depsipeptide companeramides from a Panamanian marine cyanobacterium associated with the coibamide producer.
Vining OB; Medina RA; Mitchell EA; Videau P; Li D; Serrill JD; Kelly JX; Gerwick WH; Proteau PJ; Ishmael JE; McPhail KL
J Nat Prod; 2015 Mar; 78(3):413-20. PubMed ID: 25562664
[TBL] [Abstract][Full Text] [Related]
37. Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp.
Medina RA; Goeger DE; Hills P; Mooberry SL; Huang N; Romero LI; Ortega-Barría E; Gerwick WH; McPhail KL
J Am Chem Soc; 2008 May; 130(20):6324-5. PubMed ID: 18444611
[TBL] [Abstract][Full Text] [Related]
38. Carriebowmide, a new cyclodepsipeptide from the marine cyanobacterium Lyngbya polychroa.
Gunasekera SP; Ritson-Williams R; Paul VJ
J Nat Prod; 2008 Dec; 71(12):2060-3. PubMed ID: 19007282
[TBL] [Abstract][Full Text] [Related]
39. Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp.
Linington RG; Edwards DJ; Shuman CF; McPhail KL; Matainaho T; Gerwick WH
J Nat Prod; 2008 Jan; 71(1):22-7. PubMed ID: 18163584
[TBL] [Abstract][Full Text] [Related]
40. Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.
Matthew S; Ross C; Rocca JR; Paul VJ; Luesch H
J Nat Prod; 2007 Jan; 70(1):124-7. PubMed ID: 17253864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
